183 related articles for article (PubMed ID: 9836485)
1. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
Jahkola T; Toivonen T; Virtanen I; von Smitten K; Nordling S; von Boguslawski K; Haglund C; Nevanlinna H; Blomqvist C
Br J Cancer; 1998 Dec; 78(11):1507-13. PubMed ID: 9836485
[TBL] [Abstract][Full Text] [Related]
2. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis.
Jahkola T; Toivonen T; von Smitten K; Blomqvist C; Virtanen I
Int J Cancer; 1996 Dec; 69(6):445-7. PubMed ID: 8980244
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion.
Jahkola T; Toivonen T; Nordling S; von Smitten K; Virtanen I
Eur J Cancer; 1998 Oct; 34(11):1687-92. PubMed ID: 9893653
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C
Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993
[TBL] [Abstract][Full Text] [Related]
5. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
[TBL] [Abstract][Full Text] [Related]
7. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
[TBL] [Abstract][Full Text] [Related]
8. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
9. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.
Veronesi U; Marubini E; Del Vecchio M; Manzari A; Andreola S; Greco M; Luini A; Merson M; Saccozzi R; Rilke F
J Natl Cancer Inst; 1995 Jan; 87(1):19-27. PubMed ID: 7666458
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.
Mirza AN; Mirza NQ; Vlastos G; Singletary SE
Ann Surg; 2002 Jan; 235(1):10-26. PubMed ID: 11753038
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C in primary Merkel cell carcinoma.
Koljonen V; Jahkola T; Tukiainen E; Granroth G; Haglund C; Böhling T
J Clin Pathol; 2005 Mar; 58(3):297-300. PubMed ID: 15735164
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
16. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
Ishihara A; Yoshida T; Tamaki H; Sakakura T
Clin Cancer Res; 1995 Sep; 1(9):1035-41. PubMed ID: 9816077
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
Synnestvedt M; Borgen E; Russnes HG; Kumar NT; Schlichting E; Giercksky KE; Kåresen R; Nesland JM; Naume B
Acta Oncol; 2013 Jan; 52(1):91-101. PubMed ID: 22934555
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]